Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
Yu Jun Wong, Chen Zhaojin, Guilia Tosetti, Elisabetta Degasperi, Sanchit Sharma, Samagra Agarwal, Liu Chuan, Chan Yiong Huak, Li Jia, Qi Xiaolong, Anoop Saraya, Massimo Primignani
Clin Mol Hepatol. 2023;29(1):135-145.   Published online 2022 Sep 5     DOI: https://doi.org/10.3350/cmh.2022.0181
Citations to this article as recorded by Crossref logo
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events
Yameng Sun, Wei Chen, Shuyan Chen, Xiaoning Wu, Xinxin Zhang, Lingyi Zhang, Hong Zhao, Mingyi Xu, Yongpeng Chen, Hongxin Piao, Ping Li, Lei Li, Wei Jiang, Xiaodong Li, Huichun Xing, Xudong Liu, Yuxi Zhang, Bingqiong Wang, Jialing Zhou, Tongtong Meng, Xiny
Clinical Gastroenterology and Hepatology.2024; 22(3): 591.     CrossRef
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient
Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, Georg Semmler, Lorenz Balcar, Benedikt Silvester Hofer, Michael Schwarz, David Bauer, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Thomas Reiberger, Mattias Mandorfer
Journal of Hepatology.2024; 80(5): 744.     CrossRef
Contemporary concepts of prevention and management of gastroesophageal variceal bleeding in liver cirrhosis patients
Dmitry Victorovich Garbuzenko
World Journal of Hepatology.2024; 16(2): 126.     CrossRef
Role of Vibration-Controlled Transient Elastography in the Evaluation and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
Elizabeth E. Williams, Raj Vuppalanchi
Current Hepatology Reports.2024;[Epub]     CrossRef
Acute and non‐acute decompensation of liver cirrhosis (47/130)
Martin S. Schulz, Paolo Angeli, Jonel Trebicka
Liver International.2024;[Epub]     CrossRef
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial
Vishal C. Patel, Mark J. McPhail, Ruhama Uddin, Hassan Jafari, Vanessa Lawrence, Clair Le Boutillier, James Shearer, Nahel Yaziji, Angela Cape, Haroon Ahmed, Christopher Ward, Peter Walsh, Kevin Besly, Ane Zamalloa, Joanna Kelly, Ashis Mukhopadhya, Alicij
Trials.2024;[Epub]     CrossRef
Clinical Management practice and Therapeutic Outcomes of Chronic Liver Disease patients in the Conflicted area of North Ethiopia
Hawaz Shewatetak, Raghavendra Yarlagadda, Kotaiah Silakabattini, Ramanji Reddy Tatiparthi, Venkateswara Rao Jallepalli
Research Journal of Pharmacy and Technology.2024; : 1267.     CrossRef
Pharmacologic Treatment of Portal Hypertension
Yu Jun Wong, Juan G. Abraldes
Clinics in Liver Disease.2024;[Epub]     CrossRef
Noninvasive Assessment of Portal Hypertension
Juan Bañares, Laia Aceituno, Mònica Pons, Joan Genescà
Clinics in Liver Disease.2024;[Epub]     CrossRef
Screening for exclusion of high-risk bleeding features of esophageal varices in cirrhosis through CT and MRI
Ali Borhani, Harry Luu, Alireza Mohseni, Ziyi Xu, Mohammadreza Shaghaghi, Celestina Tolosa, Mohammad Mirza Aghazadeh Attari, Seyedeh Panid Madani, Haneyeh Shahbazian, Pegah Khoshpouri, Shadi Afyouni, Ghazal Zandieh, Ihab R. Kamel, Amy K. Kim
Clinical Imaging.2024; 110: 110168.     CrossRef
Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani
Clinical and Molecular Hepatology.2023; 29(1): 188.     CrossRef
The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
Jeong-Ju Yoo, Sang Gyune Kim
Clinical and Molecular Hepatology.2023; 29(1): 102.     CrossRef
Non-invasive tests-based risk stratification: Baveno VII and beyond
Georg Semmler, Mathias Jachs, Mattias Mandorfer
Clinical and Molecular Hepatology.2023; 29(1): 105.     CrossRef
Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
Susana G Rodrigues
Clinical and Molecular Hepatology.2023; 29(1): 110.     CrossRef
Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Nikolaos Pyrsopoulos, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(8): 1372.     CrossRef
Validation of non‐invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII
Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik, Dong Hyun Sinn
Liver International.2023; 43(9): 1966.     CrossRef
Letter: Baveno‐VI criteria to exclude large varices in patients with hepatocellular carcinoma—What have we learned?
Yu J. Wong
Alimentary Pharmacology & Therapeutics.2023; 58(6): 642.     CrossRef
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review
Luca Rinaldi, Chiara Giorgione, Andrea Mormone, Francesca Esposito, Michele Rinaldi, Massimiliano Berretta, Raffaele Marfella, Ciro Romano
Viruses.2023; 15(8): 1730.     CrossRef
Combination of Fibrosis-4, liver-stiffness measurement, and Fibroscan-AST score to predict liver-related outcomes in nonalcoholic fatty liver disease
Yu Jun Wong, Esteban Urias, Michael W. Song, Tanvi Goyal, Wei Xuan Tay, Nicole Xinrong Han, Jing Hong Loo, Tian Yu Qiu, Karn Wijarnpreecha, Yiong Huak Chan, Vincent L. Chen
Hepatology Communications.2023;[Epub]     CrossRef